Hologic expects to report total revenues of approximately $1.01B, a decrease of (5.7%) compared to the prior year period, or (6.4%) in constant currency. These preliminary results exceed the company’s most recent revenue guidance range of $960M-$985M, provided on November 9, 2023. Hologic expects non-GAAP diluted earnings per share for Q1 to be towards the high-end of the guidance range of 92c-97c provided on November 9, 2023. Consensus 94c.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on HOLX: